Influenza and Emerging Infectious Diseases

About Conference

3^rd International Conference on Influenza and Emerging Infectious Diseases is a unique international platform for Researchers, Young Scholars, Ecologists, Physicians, Consultants, Diagnostic Specialists, Practice Nurses, Students, Academicians, Pioneers including Clinical and Medical professionals from various fields: Microbiology, Virology, Immunology, Oncology, Ecology, Evolution, Community Health, Public Health, Hospital Health, Industries (Pharmaceutical, Vaccines, drugs, antimicrobials) and etc., to exchange the technical and conceptual knowledge need to encounter the infectious diseases and illness might be Food Borne, Water Borne, Air Borne, and etc. are cause of public health crises such as Crimean-Congo haemorrhagic fever (CCHF), Ebola virus disease, Marburg virus disease, Lassa fever, Middle East respiratory syndrome coronavirus (MERS-CoV), Severe Acute Respiratory Syndrome (SARS), Nipah, henipaviral diseases, Rift Valley fever (RVF), Zika, HIV, AIDS and etc.

Being witnessed the triumph of Flu 2016,Organising Committee Members are delighted to announce the next event 3^rdInternational Conference on Influenza & Emerging Infectious DiseasesduringApril 10-11, 2019inToronto, Canada.

This Unique international platform also facilitates

• New research findings and scientific books can be released.
• Collaboratewith universities, labs, research centers, industries and etc.
• Promotionfor your own labs will be feasible.
• Provides a platform to organize symposia or workshops
• Special interactive sessions will be provided.

The field ofInfectious Diseases is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. The importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Selected contributions will be published in following Journals

• Virology & Mycology
• Virology & Antiviral Research
• Journal of Vaccines & Vaccination

Details of Influenza Conferences in 2019 in the USA:

Scientific Sessions

• Influenza & Infectious Diseases
• Fungal Infectious Diseases
• Infectious Disease Epidemiology
• Clinical Infectious Diseases
• Pathological Studies
• Bacterial Infectious Diseases
• Antimicrobial Resistance and Infectious Diseases
• Viral Infectious Diseases
• Cancer & infections
• Hospital (Healthcare) Acquired Infectious Diseases
• Pediatric Infectious Diseases
• Gastrointestinal Infectious Diseases
• Diagnosis and Treatment for Infectious Diseases
• Sexually Transmitted Infectious Diseases
• Neurological Infectious Diseases
• Dermatological Infectious Diseases
• Pulmonary Infectious Diseases
• Ophthalmological Infectious Diseases
• Zoonotic Diseases
• Antigenic Variation of Flu/ Influenza Virus
• Public Health Research
• Case studies on Infectious Diseases
• Treatment for Infectious Diseases
• Coinfection: Multi Pathogen Infectious Diseases
• Non Communicable Diseases (NCDs)
• Foodborne Illness Infectious Diseases
• Nutritional Supplements and Herbal Medicines
• Rion Infectious Diseases
• Emerging Protozoan Pathogens Infectious Diseases

Related Conferences:

5th Annual Congress on Rare Diseases and Orphan Drugs, August 29-30, 2018 Boston, USA, 5th International Conference on Neglected Tropical & Infectious Diseases, August 29-30, 2018 Boston, USA, 4th International Conference on Infection, Disease Control & Prevention, May 17-18, 2019 Philadelphia, Pennsylvania, USA, 4th Annual Congress on Infectious Diseases, August 29-30, 2018 Boston, USA, 7th International Conference and exhibition on Bacteriology & Antibiotics, April 24-25, 2019 Vancouver, Canada

11th International Conference on Rare Diseases and Orphan Drugs (ICORD), September 13-16, 2018   Johannesburg, South Africa;  Orphan Drugs Summit, September 2018, The Netherlands; SMi's 7th annual Orphan Drugs and Rare Diseases UK Conference, 18–19 October 2017 London, United Kingdom

Related Societies:

USA: AIDS Healthcare Foundation, Centre for AIDS Research, Northland Cares, Arizona, The McGregor Clinic, Inc., Canadian Public Health Association, Tropical Pathology & Infectious Diseases Associations, International Society for Infectious Diseases, AIDS United, HIV.gov, AmfAR, UNAIDS, The Elizabeth Taylor AIDS Foundation, International AIDS Society, International HIV/AIDS Alliance, Addiction Research and Treatment Corporation, AIDS Community Research Initiative of America, Albert Einstein College of Medicine, Community Healthcare Network, Elmhurst Hospital Center, Evergreen AIDS Foundation, Lifelong AIDS Alliance

Europe: European Society for Clinical Microbiology and Infectious Diseases,  British Society for Antimicrobial Chemotherapy, Society for General Microbiology

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Market Analysis Report

Infectious Disease Therapeutics Market (drugs & vaccine) was valued at US$ 105.13 Billion in 2018 and expected to reach USD 179.70 Billion by the end of 2025 with a growing potential of 7.96 %.

Top 6 Infectious Diseases (HIV, malaria, hepatitis, influenza, Human Papillomavirus (HPV), and tuberculosis) therapeutics market worth $86.2 Billion By 2025

The global Influenza therapeutics market was valued USD 1699.7 Million in 2016, and is estimated to reach US$ 2012.6 Million by 2025, with a growth potential of 1.4% 

Major factors those are driving the growth of the market:

• Increasing the occurrence of infectious diseases
• Growing use of direct acting anti-viral
• Increasing healthcare expenditure
• Increasing geriatric population,
• Growing healthcare awareness
• Increasing government funding’s in developing countries.
• The major factor restraining the growth of the market is generic erosion, Patent expiration of infectious disease drugs.

Regional wise Infectious disease Therapeutics Market

• North America: USA & Canada
• Europe: Germany, UK, France, Spain, Italy, Nordic countries, Benelux, Poland & Russia
• Asia Pacific: China, India, Japan, ASEAN, Australia, and New Zealand
• Latin America: Brazil & Mexico
• Middle East & Africa: GCC, Southern Africa, North Africa

Therapeutics

• Anti-infective drugs: Antibacterial, antifungal, antiparasitic, and antiviral drugs are some of the anti-infective drugs used for the treatment of infectious diseases.
• Vaccines

End users:

• Pediatrics
• Adolescence
• Adults
• Elderly

Disease type therapeutics market  

HIV

• Emtriva
• Aptivus
• Isentress
• Lexiva/Telzir
• Selzentry
• Tivicay
• Atripla
• Complera
• Genvoya
• Odefsey
• Stribild
• Truvada
• Triumeq
• Descovy
• Vitekta

Influenza

• Relenza
• Tamiflu
• Rapivab

TB

• Sirturo

Malaria

• Coartem

HPV

Hepatitis

Key Players of Infectious disease Therapeutics Market

• Abbott Laboratories
• AbbVie, Astellas Pharma
• Achillion Pharmaceuticals
• Astrazeneca PLC
• AstraZeneca, Auritec Pharmaceuticals
• Bayer
• Biocryst Pharmaceuticals Inc.
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb
• Chimerix Pharmaceuticals
• Chiron Corporation
• CSL Limited
• Cubist, Eli Lilly
• Daiichi Sankyo Co. Ltd.
• F. Hoffmann-La Roche AG
• Gilead Sciences
• Gilead Sciences, Inc.
• Glaxosmithkline PLC
• Isis Pharmaceuticals
• Janssen Pharmaceutical
• Johnson & Johnson
• Pfizer
• Merck & Co., Inc.
• Mitsubishi Tanabe Pharma Corporation
• Nanotherapeutics Inc.
• Novartis International AG
• Protein Sciences Corporation
• pSivida
• Roche Holding AG
• Sanofi SA
• Shionogi & Co. Ltd.
• Sinovac Biotech Ltd.

Reference:

• Centers for Disease Controle and Prevention
• National Institute of Allergy and Infectious Diseases
• Infectious Diseases Society of America
• Business Wire
• Research and Markets
• Future Market Insights
• Credence Research
• Yahoo finance
• Industry Experts Inc.
• BCC Research
• PR Newswire Association LLC
• Report Buyer
• Market Data Forecast
• Grand View Research, Inc.
• Transparency Market Research
• Persistence Market Research
• Coherent Market Insights
• Influenza Research Database
• Influenza Reagent Resource
• BEI Resources
• ATCC

Visa Information

Issue with VISA!!

Are you planning to have a professional and delightful trip to Toronto, Canada???

We believe you must be having a query regarding your Visa to Visit as a Speaker/Delegate, Tourist or Business Person at Toronto, Canada. Influenza Research Committee will be happy to help you in all regards to plan your trip to Toronto, Canada. Here is the simplest way to know the process for your Visa Approval. Kindly drop us an email at . Avail the official invitation letter from us to attend this event ahead with a closer step for approval of your VISA. Processing time for visa applications vary depending on the office and the time of the year. Delegates/Attendees are encouraged to submit their visa applications well in advance of the date of the event at a Visa Application Centre or on-line E-applications, including all supporting documents.

Past Conference Report

Flu-2015

International Conference on Flu (Flu-2015) was convened by Conference Series LLC Ltd during June 08-10, 2015 at DoubleTree by Hilton Hotel Chicago-North Shore, USA. The meeting brought together a group of clinicians, virologists and industry representatives with interest and expertise in the field of influenza research. The three day program witnessed thought provoking keynote and plenary presentations from experts in the field of virology, immunology and microbiology, highlighting the theme, “Advanced Research in Flu".

Flu-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Rupert Beale, University of Cambridge, UK who contributed a lot for the smooth functioning of this event.

In the opening remark welcome note was given by Dr. Scott Umlauf, the support was extended by Honorable guests and Keynote Speakers of Flu-2015:
Scott Umlauf, VaxInnate Corporation, USA
Vadim Bichko ChemDiv, Inc, USA
Joshua DiNapoli, Sanofi Pasteur Biologics LLC, USA
Rangaraj Selvarangan, Children’s Mercy Hospitals and Clinics, USA
Ming Zhang, University of Georgia, USA.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures. Also the conference was featured with Workshop and Symposium.

Workshop: A workshop on “Designing effective flu vaccines against a broad- spectrum of influenza viruses” organized by Dr. Pamuk Bilsel, FluGen Inc USA.

Symposium: A symposium on “Novel jet injection technology for influenza vaccination” organized by Dr. Chris Cappello, PharmaJet Inc, USA and Charles A Altman, bioCSL, USA.

We would like to thank the Poster Competition Judge Scott Umlauf, VaxInnate Corporation,USA for his valuable time. On behalf of the Conference Series LLC Ltd, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Best Poster Winners:

Janice Koshy, Baylor Scott & White Infectious Diseases Department, USA
Harshini Ashar, Oklahoma State University, USA

Conference Series LLC Ltd also took the privilege of felicitating Flu-2015, Chair and Co-Chairs whose support made conference a great success.
Pamuk Bilsel, FluGen, Inc, USA
Masayuki Noguchi, Hokkaido University, Japan
Rob Lambkin-Williams, hVIVO, UK
Benicio Gutiérrez-Doña, Universidad Estatal a Distancia, Costa Rica

For enjoy and sharing the memories about conference kindly follow the link: Flu-2015 Gallery

To continue our engagement against influenza and to be prepared for the next outbreak we need further global efforts to understand viral mechanisms, host-pathogen interactions and immunological pathways. Conference Series LLC Ltd welcome all the 2nd International Conference on Flu during October 31- November-02 2016, at San Francisco, USA. We invite all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Influenza research.

                                                                           Let us [email protected] Flu-2016

Conference series llc LTD hosted the “2^nd International Conference on Flu” during October 31-November 02, 2016 at DoubleTree by Hilton Hotel San Francisco Airport, San Francisco, USA with the theme “Scientific Milestones in Understanding and Preventing Flu” where eminent keynote speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering.

Benevolent response and active participation was received from the renowned experts and Editorial Board Members of Conference series Journals as well as from the Immunologists, Virologists, scientists, researchers, students and leaders in Flu Research, who made this event successful.

The Conference was carried out through various informative and cutting edge sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

• Flu Vaccines: Current and Novel Approach
• Pathology of Influenza Virus Infections
• Flu Symptoms & Treatment
• Antivirals and Therapeutics
• Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups
• Flu Virus -Advancements in Detection & Differentiation
• Flu: Immunology & Genetics
• Flu Clinical Studies & Case Reports
• Epidemiology and Public Health of Influenza
• Surveillance Issues and Burden of Disease

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

Notable Keynotes:

• Donald P Francis, Global Solutions for Infectious Diseases, USA
• Ananda M Chakrabarty, University of Illinois College of Medicine, USA
• Anthony S Gilbert, hVIVO, UK
• Palayakotai Raghavan, Nanorx Inc, USA
• Manon M J Cox, Protein Sciences, USA
• Phillip Bertrand Berkey Moheno, SanRx Pharmaceuticals Inc; USA
• Sunil K Lal, Monash University, Malaysia

All the above mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Honorable Moderator Jun Wang, University of Arizona, USA and Sunil K Lal, Monash University, Malaysia for his remarkable contribution towards smooth functioning at Flu-2016 Conference.

Conference Sessions Chairs:      

• Donald P Francis, Global Solutions for Infectious Diseases, USA
• Palayakotai Raghavan, Nanorx Inc, USA
• Phillip Bertrand Berkey Moheno, SanRx Pharmaceuticals Inc; USA

For further information visit : Flu 2016

Conference Series llc LTD offers its heartfelt appreciation to Societies and Organizations includes Allied Academies, Andrew John Publishing Inc., New York Private Equity Forums and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference series llc LTD in supporting and making the conference a never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph Flu-2016, Conference Series llc LTD is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, "3^rd International Conference on Flu & Emerging Infectious Diseases" to be held during September 17-18, 2018 at San Diego, USA.

Let us meet again @ Flu-2018